Aloha, MauiBound, it is funny, isn't it - for some here it's not enough that Amarantus multiplies its market cap in the months ahead. No, AMBS must progress according to a precise schedule. I really should keep quiet as I hope to capitalize on any raised expectations and subsequent short-term disappointment ... moving funds now, and hoping to buy cheaper shares soon.
I've spent two decades working in a creative industry where deadlines constantly shift for various reasons and I imagine that biotech may be similar in that regard. I don't know if corporate milestones are more predictable in financial and insurance businesses, but I'm guessing yes and that might explain some of the attitudes here.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links